| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | PalBociclib Impurity 23 Basic information |
| Product Name: | PalBociclib Impurity 23 | | Synonyms: | PalBociclib Impurity 23;Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[3-(1-piperazinyl)-2-pyridinyl]amino]- | | CAS: | 2205035-04-5 | | MF: | C24H29N7O2 | | MW: | 447.53 | | EINECS: | | | Product Categories: | | | Mol File: | 2205035-04-5.mol |  |
| | PalBociclib Impurity 23 Chemical Properties |
| Boiling point | 694.5±65.0 °C(Predicted) | | density | 1.313±0.06 g/cm3(Predicted) | | pka | 8.63±0.10(Predicted) |
| | PalBociclib Impurity 23 Usage And Synthesis |
| Uses | Palbociclib Impurity A is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 3-Fluoro-2-nitropyridine (F597685). |
| | PalBociclib Impurity 23 Preparation Products And Raw materials |
|